Clinical response to ustekinumab in familial pityriasis rubra pilaris caused by a novel mutation inCARD14
- 6 August 2014
- journal article
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 171 (2) , 420-422
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- Treatment Options for Pityriasis Rubra Pilaris Including Biologic AgentsJAMA Dermatology, 2014
- Familial Pityriasis Rubra Pilaris Is Caused by Mutations in CARD14The American Journal of Human Genetics, 2012
- Rare and Common Variants in CARD14, Encoding an Epidermal Regulator of NF-kappaB, in PsoriasisThe American Journal of Human Genetics, 2012
- PSORS2 Is Due to Mutations in CARD14The American Journal of Human Genetics, 2012
- The IL23/Th17 Pathway as a Therapeutic Target in Chronic Inflammatory DiseasesInflammation & Allergy - Drug Targets, 2012
- Treatment of pityriasis rubra pilaris with ustekinumabBritish Journal of Dermatology, 2010
- Involvement of NF-κB signalling in skin physiology and diseaseCellular Signalling, 2003
- CARD11 and CARD14 Are Novel Caspase Recruitment Domain (CARD)/Membrane-associated Guanylate Kinase (MAGUK) Family Members that Interact with BCL10 and Activate NF-κBJournal of Biological Chemistry, 2001
- Familial Pityriasis Rubra PilarisArchives of Dermatology, 1995